Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, LifeMD Inc’s stock clocked out at $11.54, up 0.09% from its previous closing price of $11.53. In other words, the price has increased by $0.09 from its previous closing price. On the day, 1.47 million shares were traded.
Ratios:
To gain a deeper understanding of LFMD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.62. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’25 when Schreiber Justin sold 21,995 shares for $7.53 per share. The transaction valued at 165,684 led to the insider holds 2,553,726 shares of the business.
Schreiber Justin sold 3,005 shares of LFMD for $22,539 on May 02 ’25. The Chairman and CEO now owns 2,550,721 shares after completing the transaction at $7.50 per share. On Apr 29 ’25, another insider, Schreiber Justin, who serves as the Chairman and CEO of the company, sold 50,000 shares for $7.78 each. As a result, the insider received 389,040 and left with 2,575,721 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.24.
Stock Price History:
Over the past 52 weeks, LFMD has reached a high of $11.65, while it has fallen to a 52-week low of $3.99. The 50-Day Moving Average of the stock is 65.22%, while the 200-Day Moving Average is calculated to be 99.98%.
Shares Statistics:
A total of 43.53M shares are outstanding, with a floating share count of 36.13M. Insiders hold about 20.51% of the company’s shares, while institutions hold 36.40% stake in the company.
Earnings Estimates
The current assessment of LifeMD Inc (LFMD) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.16, with high estimates of $0.16 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.64 and $0.0 for the fiscal current year, implying an average EPS of $0.32. EPS for the following year is $0.6, with 2.0 analysts recommending between $0.95 and $0.25.
Revenue Estimates
In the current quarter, 8 analysts expect revenue to total $66.3M. It ranges from a high estimate of $67.71M to a low estimate of $65.3M. As of the current estimate, LifeMD Inc’s year-ago sales were $50.66MFor the next quarter, 8 analysts are estimating revenue of $67.76M. There is a high estimate of $68.69M for the next quarter, whereas the lowest estimate is $67M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $273.23M, while the lowest revenue estimate was $266.8M, resulting in an average revenue estimate of $270.32M. In the same quarter a year ago, actual revenue was $212.45MBased on 7 analysts’ estimates, the company’s revenue will be $318.23M in the next fiscal year. The high estimate is $355M and the low estimate is $297.5M.
